No Data
No Data
Brokerage morning meeting highlights: Countermeasures against tariffs boost Shenzhen Agricultural Products Group prices, the planting chain directly benefits.
At today's Brokerage morning meeting, CITIC SEC believes that countermeasures against tariffs boost the prices of Shenzhen Agricultural Products Group, which directly benefits the planting chain; HAITONG SEC proposed a bullish view on the relative yields of the Banks Sector in April; Galaxy Securities stated that it focuses on Gold and countermeasures against rare earths.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Yisheng Pharmaceutical: Report for the third quarter of 2024
Jilin Jian Yisheng Pharmaceutical: Half-year report for the year 2024.
Jilin Jian Yisheng Pharmaceutical: Summary of Half-Year Report in 2024.
Jilin Jian Yisheng Pharmaceutical (002566.SZ): The net income in the first half of the year was 33.3358 million yuan, a year-on-year decrease of 29.71%.
Jilin Jian Yisheng Pharmaceutical (002566.SZ) announced its semi-annual report for 2024, with a total operating income of 0.348 billion yuan during the reporting period, a year-on-year decrease of 25.90%; the net income attributable to shareholders of the listed company was 33.3358 million yuan, a year-on-year decrease of 29.71%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 20.3051 million yuan, a year-on-year decrease of 45.04%; the basic earnings per share was 0.1007 yuan.